BioSpace News Archive

Noting that from 1998 to 2017 there have been about 146 failed shots at developing drugs for Alzheimer’s disease, PhRMA released a report on the state of the industry. This would not lead most people to think there are many reasons to be optimistic about Alzheimer’s disease research, but the report does believe there are good reasons to be.

Many of these directors do not publicly disclose their affiliation with the pharma companies in their nonprofit biographies, report shows.

The successful synthesis of large-area single-crystal heterostructure of 2D materials

LimaCorporate is pleased to announce the launch of the SMR TT Hybrid Glenoid, the latest addition to the SMR Shoulder System.

Transaction would expand Ecolab’s offerings for life sciences and healthcare environments

As Mo Bros across Canada prepare to farewell their moustaches on November 30, the Movember Foundation is urging them to shave-down to a ‘Half-Mast Mo’ in one final fundraising act for men’s health.

LabCorp® today updated its full-year 2018 guidance based on current expectations. In the following guidance, all comparisons to financial results in 2017 have been restated as if the Company had adopted the FASB-issued converged standard on revenue recognition (ASC 606) on January 1, 2017.

Top researchers will present abstracts on latest clinical research advancing cancer treatment options

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares.

Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have observed that, during a natural vaginal birth, specific bacteria from the mother’s gut are passed on to the baby and stimulate the baby’s immune responses.